A clinical study on injectable contraceptive Noristerat.
Results of a clinical study involving 382 subjects using the injectable contraceptive Noristerat (norethisterone enanthate) is presented.  The maximum number of acceptors were between 21-25 years of age and had been married for 6-10 years.  50% began their 1st injection within 1 year of the last childbirth.  Continuation rates were very high and about 75% returned for their 2nd injection.  Among the users, weight gain was seen more commonly than weight loss.  There was no significant change in blood pressure.  52.2% reported a menstrual pattern which was within the acceptable range of normal, while only 12.7% had amenorrhea.  15% showed other types of menstrual disturbance.  Only 1 woman in the series became pregnant.  Menstrual abnormality was the most common cause for discontinuation among the 71 subjects available for interview.
Chowdhury
T A
TA
D017677:Age Distribution; D000367:Age Factors; D001208:Asia; D001459:Bangladesh; D001695:Biology; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003710:Demography; D003906:Developing Countries; D003933:Diagnosis; D004467:Economics; D004522:Educational Status; D004703:Endocrine System; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006728:Hormones; D007267:Injections; D017533:Marital Status; D008597:Menstrual Cycle; D008598:Menstruation; D009640:Norethindrone; D010298:Parity; D010827:Physiology; D011153:Population; D011154:Population Characteristics; D012098:Reproduction; D012102:Reproductive Control Agents; D012106:Research; D012107:Research Design; D012725:Sexual Behavior; D013672:Technology
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D006728:Hormones; D012102:Reproductive Control Agents; D009640:Norethindrone
Age Distribution; Age Factors; Asia; Bangladesh; Biology; Clinical Research; Contraception; Contraception Termination; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Effectiveness; Contraceptive Methods; Contraceptive Usage; Demographic Factors; Developing Countries; Economic Factors; Educational Status; Endocrine System; Evaluation; Examinations And Diagnoses; Family Planning; Hormones; Injectables; Marital Status; Measurement; Menstrual Cycle--changes; Menstruation; Norethindrone; Norethindrone Enanthate; Parity; Physiology; Population; Population Characteristics; Qualitative Evaluation; Reproduction; Reproductive Behavior; Reproductive Control Agents; Research And Development; Research Methodology; Southern Asia; Technology; Use-effectiveness